GlassScriptPhysician profile
Brenda Silva
NPI 1447337092
$1,174.31
in general payments reported to CMS, 2019-2025
11 companies · $740 in 2025
The $740 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $14.53 · 2024: $420 · 2025: $740.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,159.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $377.76 | 2024-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $237.01 | 2024-2025 | Zepbound, Mounjaro |
| Abbvie INC. | $146.18 | 2022-2025 | |
| Novo Nordisk INC | $127.69 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Abbott Laboratories | $102.12 | 2024 | Freestyle Libre 3 |
| Pfizer INC. | $74.41 | 2024-2025 | |
| Amgen INC. | $43.27 | 2025 | Repatha, Otezla |
| Inspire Medical Systems, INC. | $18.65 | 2025 | Inspire |
| Antares Pharma, INC. | $17.13 | 2024 | Xyosted |
| Bayer Healthcare Pharmaceuticals INC. | $15.25 | 2025 | |
| Exact Sciences Corporation | $14.84 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brenda Silva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.